Victory Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$456M Sell
3,789,757
-1,018,770
-21% -$118M 0.29% 68
2025
Q4
$506M Buy
4,808,527
+75,204
+2% +$7.06M 0.29% 72
2025
Q3
$397M Buy
4,733,323
+301,155
+7% +$24.8M 0.23% 91
2025
Q2
$351M Sell
4,432,168
-34,832
-0.8% -$2.77M 0.23% 98
2025
Q1
$401M Buy
4,467,000
+1,121,878
+34% +$105M 0.41% 35
2024
Q4
$333M Buy
3,345,122
+371,758
+13% +$38.3M 0.33% 66
2024
Q3
$338M Buy
2,973,364
+150,873
+5% +$17.9M 0.33% 69
2024
Q2
$349M Sell
2,822,491
-7,355
-0.3% -$947K 0.35% 62
2024
Q1
$373M Sell
2,829,846
-65,119
-2% -$8.03M 0.36% 61
2023
Q4
$316M Buy
2,894,965
+327,286
+13% +$34M 0.33% 72
2023
Q3
$264M Buy
2,567,679
+16,251
+0.6% +$1.75M 0.3% 79
2023
Q2
$294M Sell
2,551,428
-224,688
-8% -$25.5M 0.32% 75
2023
Q1
$295M Sell
2,776,116
-1,105,479
-28% -$119M 0.33% 67
2022
Q4
$431M Sell
3,881,595
-82,691
-2% -$8.45M 0.5% 19
2022
Q3
$341M Buy
3,964,286
+545,018
+16% +$48.7M 0.4% 37
2022
Q2
$312M Sell
3,419,268
-67,060
-2% -$5.95M 0.36% 49
2022
Q1
$306M Buy
3,486,328
+668,123
+24% +$52.7M 0.31% 64
2021
Q4
$216M Buy
2,818,205
+48,130
+2% +$3.83M 0.2% 117
2021
Q3
$208M Buy
2,770,075
+59,679
+2% +$4.54M 0.2% 112
2021
Q2
$211M Buy
2,710,396
+662,407
+32% +$49.3M 0.2% 117
2021
Q1
$151M Sell
2,047,989
-70,125
-3% -$5.17M 0.15% 154
2020
Q4
$165M Sell
2,118,114
-170,862
-7% -$13.1M 0.18% 125
2020
Q3
$181M Buy
2,288,976
+44,775
+2% +$3.51M 0.23% 90
2020
Q2
$166M Sell
2,244,201
-4,405,720
-66% -$332M 0.22% 96
2020
Q1
$488M Buy
6,649,921
+2,449,190
+58% +$192M 0.41% 25
2019
Q4
$365M Sell
4,200,731
-342,887
-8% -$28.2M 0.44% 17
2019
Q3
$365M Buy
4,543,618
+3,957,180
+675% +$317M 0.47% 14
2019
Q2
$46.9M Buy
586,438
+408,074
+229% +$31.2M 0.09% 331
2019
Q1
$14.2M Buy
178,364
+52,190
+41% +$3.9M 0.03% 644
2018
Q4
$9.2M Sell
126,174
-56,034
-31% -$3.96M 0.02% 735
2018
Q3
$12.3M Sell
182,208
-10,507
-5% -$669K 0.03% 730
2018
Q2
$11.2M Buy
192,715
+148,427
+335% +$8.37M 0.02% 743
2018
Q1
$2.3M Sell
44,288
-1,684
-4% -$90.9K 0.01% 1032
2017
Q4
$2.47M Sell
45,972
-1,997
-4% -$111K 0.01% 965
2017
Q3
$2.93M Sell
47,969
-114,412
-70% -$6.94M 0.01% 891
2017
Q2
$9.93M Buy
162,381
+12,090
+8% +$736K 0.02% 706
2017
Q1
$9.11M Sell
150,291
-9,165
-6% -$556K 0.02% 706
2016
Q4
$8.96M Sell
159,456
-545,480
-77% -$31.9M 0.02% 693
2016
Q3
$42M Sell
704,936
-136,168
-16% -$7.96M 0.12% 299
2016
Q2
$46.2M Buy
841,104
+116,015
+16% +$6.17M 0.18% 192
2016
Q1
$36.6M Sell
725,089
-97,377
-12% -$4.77M 0.15% 235
2015
Q4
$41.5M Sell
822,466
-211,152
-20% -$10.6M 0.17% 203
2015
Q3
$48.7M Sell
1,033,618
-251,608
-20% -$13.4M 0.2% 156
2015
Q2
$69.8M Sell
1,285,226
-570,261
-31% -$32M 0.26% 113
2015
Q1
$102M Sell
1,855,487
-637,416
-26% -$36.1M 0.37% 65
2014
Q4
$135M Buy
2,492,903
+28,255
+1% +$1.57M 0.5% 32
2014
Q3
$139M Sell
2,464,648
-301,009
-11% -$16.9M 1.05% 11
2014
Q2
$153M Sell
2,765,657
-379,497
-12% -$20.7M 1.04% 11
2014
Q1
$170M Buy
3,145,154
+266,528
+9% +$13.8M 1.16% 5
2013
Q4
$137M Sell
2,878,626
-771,140
-21% -$35.2M 0.97% 11
2013
Q3
$166M Buy
+3,649,766
New +$167M 1.19% 7

Other funds holding MRK

Victory Capital Management's MRK Position: Q1 2026 in Review

Victory Capital Management reduced its Merck (MRK) stake by 21% in Q1 2026, selling an estimated $118M and leaving 3,789,757 shares worth $456M. The position accounts for 0.29% of the portfolio, ranked #68.

Victory Capital Management first reported a position in MRK in Q3 2013 and has held it in 51 quarters since. The position peaked at $506M in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Victory Capital Management held 3,789,757 shares of Merck worth $456M as of Q1 2026.
  • Victory Capital Management sold 1,018,770 Merck shares in Q1 2026, an estimated $118M.
  • Merck made up 0.29% of Victory Capital Management's portfolio in Q1 2026, its #68 holding.
  • Victory Capital Management first reported a position in Merck in Q3 2013 and has held it in 51 quarters since.
  • Victory Capital Management's Merck position peaked at $506M in Q4 2025.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.